EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Decoding Immunotherapy Response in Colorectal Cancer: Translational Insights Beyond MSI

Chiara Cataldi iD, Beliz Bahar Karaoğlan iD, Elena Liotta iD, Sara De Dosso iD

Cancers · 06.03.2026 · 18 (5) · 852

DOI: 10.3390/cancers18050852 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 06.03.2026. Verfasst von Chiara Cataldi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Immune checkpoint inhibitors (ICIs) are among the transformative and manageable systemic therapies for several cancer types, including colorectal cancer (CRC). Nevertheless, their clinical benefit is limited to mismatch-deficient or microsatellite instability-high diseases, which represent only a small percentage of cases. Despite this initial major and stringent selection, primary and acquired resistance remain clinically relevant. Therefore, the identification of additional biomarkers is essential to refine patient selection and guide rational combinational strategies. This review aims to summarize the current evidence regarding established and emerging biomarkers of response and resistance to ICIs in CRC.

Methods

This narrative review identified and synthesized relevant clinical trials, translational studies, and reviews through a literature search of emerging biomarkers of immunotherapy response in colorectal cancer.

Results

Deficient mismatch repair/high microsatellite instability remains the most reliable predictive biomarker of ICI response, emphasized by high tumor mutational burden, POLE/POLD mutations, and specific tumor microenvironment features. Emerging indicators, including molecular alterations, antigen presentation machinery integrity, PD-L1-mediated signaling, microbiome connections, and circulating tumor DNA kinetics, have demonstrated significant potential as sources for therapeutic response prediction and have informed the development of innovative combination strategies in both MSI-H and MSS CRCs.

Conclusions

Immunotherapy response in CRC is determined by a complex interplay between tumor-intrinsic, immune, microenvironmental, and systemic factors. Integrating multiple biomarkers may provide superior stratification and guide therapeutic strategies. Prospective validation and standardized biomarker assessment will be imperative to translate these insights into clinical practice.

Schlagwörter

Stichwörter der Autor:innen

biomarkerscolorectal cancerimmunotherapy

Autor:innen und Institutionen

  • Department of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.
  • Eskişehir City Hospital, 26080 Eskişehir, Turkey.
  • Department of Radiological, Oncological and Pathological Science, Sapienza University of Rome, 00161 Rome, Italy.
  • Medical Oncology Department, Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), 6500 Bellinzona, Switzerland.
  • Faculty of Biomedical Sciences, University of Southern Switzerland (USI), 6900 Lugano, Switzerland.

ORCID-Profile: Chiara Cataldi, Beliz Bahar Karaoğlan, Elena Liotta, Sara De Dosso

Zitieren

APA

Cataldi, C., Karaoğlan, B. B., Liotta, E., & De Dosso, S. (2026). Decoding Immunotherapy Response in Colorectal Cancer: Translational Insights Beyond MSI. Cancers, 18(5), 852. https://doi.org/10.3390/cancers18050852

Vancouver

Cataldi C, Karaoğlan BB, Liotta E, De Dosso S. Decoding Immunotherapy Response in Colorectal Cancer: Translational Insights Beyond MSI. Cancers. 2026;18(5):852. doi:10.3390/cancers18050852

BibTeX
@article{Cataldi2026,
  author = {Cataldi, Chiara and Karaoğlan, Beliz Bahar and Liotta, Elena and De Dosso, Sara},
  title = {Decoding Immunotherapy Response in Colorectal Cancer: Translational Insights Beyond MSI},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {5},
  pages = {852},
  doi = {10.3390/cancers18050852}
}
Kostenlos starten →